Ken Griffin Immuno Gen, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.46 - $29.95 $6.13 Million - $14.7 Million	-492,084 Reduced 38.22%	795,458 $23.6 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $5.06 Million - $7.14 Million	359,302 Added 38.71%	1,287,542 $20.4 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $175,567 - $938,700	-46,818 Reduced 4.8%	928,240 $17.5 Million
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $3.48 Million - $4.67 Million	948,435 Added 3562.46%	975,058 $3.74 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $6.43 Million - $8.92 Million	-1,413,786 Reduced 98.15%	26,623 $132,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $1.84 Million - $2.65 Million	-409,632 Reduced 22.14%	1,440,409 $6.89 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $3.5 Million - $6.41 Million	1,112,373 Added 150.8%	1,850,041 $8.33 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $1.69 Million - $2.97 Million	-397,483 Reduced 35.02%	737,668 $3.51 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $2.43 Million - $3.84 Million	511,587 Added 82.04%	1,135,151 $8.42 Million
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $2.36 Million - $3.5 Million	407,084 Added 188.05%	623,564 $4.11 Million
Q1 2021 May 17, 2021	SELL	$6.5 - $10.53 $9.87 Million - $16 Million	-1,518,367 Reduced 87.52%	216,480 $1.75 Million
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $4.06 Million - $8.41 Million	1,097,928 Added 172.38%	1,734,847 $11.2 Million
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $1.62 Million - $2.3 Million	470,663 Added 283.1%	636,919 $2.29 Million
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $1.64 Million - $2.63 Million	-492,808 Reduced 74.77%	166,256 $765,000
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $1.32 Million - $4.23 Million	-622,227 Reduced 48.56%	659,064 $2.25 Million
Q4 2019 Feb 14, 2020	BUY	$2.25 - $5.8 $1.76 Million - $4.53 Million	781,347 Added 156.29%	1,281,291 $6.54 Million
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $1.14 Million - $1.74 Million	-513,376 Reduced 50.66%	499,944 $1.21 Million
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $1.26 Million - $2.31 Million	698,528 Added 221.9%	1,013,320 $2.2 Million
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $5.56 Million - $13.6 Million	-2,305,912 Reduced 87.99%	314,792 $0
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $1.24 Million - $3.06 Million	315,028 Added 13.66%	2,620,704 $12.6 Million
Q3 2018 Nov 13, 2018	BUY	$8.6 - $11.26 $3.77 Million - $4.93 Million	437,848 Added 23.44%	2,305,676 $0
Q2 2018 Aug 10, 2018	BUY	$9.52 - $12.15 $13.5 Million - $17.2 Million	1,415,096 Added 312.57%	1,867,828 $0
Q1 2018 May 11, 2018	BUY	$6.7 - $12.95 $1.94 Million - $3.75 Million	289,783 Added 177.84%	452,732 $4.76 Million
Q4 2017 Feb 09, 2018	SELL	$5.07 - $7.92 $187,032 - $292,168	-36,890 Reduced 18.46%	162,949 $1.05 Million
Q3 2017 Nov 09, 2017	BUY	$5.4 - $8.47 $1.08 Million - $1.69 Million	199,839	199,839 $1.53 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account